Elizabeth Holmes: From CEO to criminal

16 Feb 2026 · 48 min · 28 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Good Bad Billionaire: Elizabeth Holmes - From CEO to Criminal

Episode Overview In this episode of *Good Bad Billionaire*, hosts Simon Jack and Zing Tsjeng examine the rise and fall of Elizabeth Holmes, the former CEO of Theranos, who went from being celebrated as a visionary to being convicted of fraud. Holmes was once the youngest self-made female billionaire, claiming to revolutionize healthcare with her company, but ended up facing a monumental scandal that highlighted the darker side of Silicon Valley ambitions.

Key Concepts and Discussions

Background of Elizabeth Holmes

  • Early Life: Born on February 3, 1984, into a family with a history of achievement, including connections to significant figures in U.S. government.
  • Early Ambitions: From a young age, Holmes aimed to be a billionaire and displayed prodigious talents, including reading Moby Dick at age nine and attempting to design a time machine at seven.
  • Stanford University: Enrolled in chemical engineering and pursued research, which led to her dropping out to start her company, Theranos.

Theranos and its Promises

  • Foundation of Theranos: Founded in 2003 with the promise of conducting hundreds of blood tests with just a drop of blood using microfluidics technology.
  • Initial Funding: Raised $6 million by early 2005, quickly valuing the company at $30 million.
  • Hype and Secrecy: Utilized secrecy to create a buzz around the technology, which ultimately led to skepticism among insiders and investors.

The Rise of a Billionaire

  • Expanding Investor Network: Attracted high-profile investors like Larry Ellison and Rupert Murdoch, boosting her credibility.
  • Media Portrayal: Featured in *Inc.* magazine alongside young tech leaders, enhancing her image as a capable entrepreneur.
  • Corporate Partnerships: Secured deals with major companies like Walgreens, despite the technology being unproven.

The Downfall

  • Journalistic Exposé: The *Wall Street Journal* published an article in 2015 that exposed the truth about Theranos's technology, initiating a series of investigations.
  • Legal Consequences: Holmes was charged with fraud and conspiracy, eventually being found guilty and sentenced to 11 years in prison.
  • Impact of the Scandal: The scandal resulted in the collapse of Theranos, loss of investor funds, and harm to patients due to incorrect test results.

Key Takeaways

Wealth and Ambition

  • Wealth Trajectory: Holmes's journey exemplifies a rapid rise to wealth followed by a dramatic fall, raising questions about ethics and responsibility in the tech industry.
  • Vision and Reality: The episode illustrates the dangers of "fake it till you make it" culture, especially in critical industries like healthcare.

Controversy and Ethics

  • Lying to Investors: Holmes's willingness to fabricate results and mislead investors reflects a significant ethical breach.
  • Corporate Culture at Theranos: The atmosphere of fear and secrecy contributed to the unethical practices that ultimately led to the company's demise.

Legacy and Reflection

  • Cautionary Tale: Holmes's story serves as a warning about the extremes of ambition and the potential consequences of ignoring ethical considerations in business.
  • Impact on Female Entrepreneurs: The repercussions of her actions may affect the scrutiny that future female entrepreneurs face, highlighting systemic issues in the tech industry.

Final Reflections The hosts conclude that Elizabeth Holmes's story is one of both caution and intrigue, embodying the complexities of ambition, the flaws of the corporate ecosystem, and the consequences of deception. As always, listeners are encouraged to weigh in with their thoughts on whether Holmes is perceived as a "good," "bad," or just another billionaire, making the episode not only informative but also interactive.

Contact Information Listeners are invited to share their opinions on the episode via email at [goodbadbillionaire@bbc.com](mailto:goodbadbillionaire@bbc.com) or through WhatsApp at +1 (917) 686-1176.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

The Rise of Elizabeth Holmes

0:30 to 2:18

Overview of Elizabeth Holmes' early life and ambitions as a billionaire.

“Listen on BBC.com or wherever you get your podcasts.”

Holmes' Unique Background and Aspirations

2:18 to 3:53

Exploration of Elizabeth's family background and her childhood aspirations.

“and her net worth slashed from$4.5 billion to zero.”

Education and Early Achievements

3:53 to 5:48

Discussion of Elizabeth's education at Stanford and early academic accomplishments.

“She told the New Yorker she read Moby Dick, which is a big book for those who don't know it, from start to finish when she was nine.”

Initial Ventures and Idea Development

5:48 to 7:52

Details on the inception of her blood testing technology and challenges faced.

“As a freshman, she persuaded Professor Channing Robinson to let her work in his lab, an opportunity usually reserved for graduate students.”

Funding and Company Growth

7:52 to 9:50

Narrative on Elizabeth's fundraising efforts and the early growth of Theranos.

“I mean, if you think that you can apply patches to push stuff in, like nicotine patches, If you can use a patch to push stuff through the skin that way, maybe you can use a patch to pull stuff out the other way.”

Building Her Vision

9:50 to 14:00

Insight into Elizabeth's ambition and shifts in her business strategy.

“So although Elizabeth's$6 million was raised to fund her startup by the beginning of 2005, it's safe for us to say that she is now a millionaire.”

Understanding the Jargon of Theranos

14:00 to 15:00

Explore the buzzwords and investor mentality surrounding Theranos.

“Yeah, there's a lot of jargon in there, which I honestly don't understand.”

The Faked Presentation in Switzerland

15:00 to 16:20

Learn about the pivotal moment when Theranos faked test results during a crucial presentation.

“But the night before the demo, the Theranos prototype kept giving error messages.”

Elizabeth Holmes' Ruthless Leadership

16:20 to 17:20

Discover how Elizabeth dealt with dissent within her ranks and the implications.

“The head of the original team was fired.”

The Evolution of the Edison Prototype

17:20 to 18:40

Examine the changes to the Edison device and their implications for Theranos.

“So again, a really kind of ruthless approach to dissent.”
Show all 28 chapters

The Cult of Personality at Theranos

18:40 to 20:20

Analyze how Elizabeth's charisma and Steve Jobs' influence shaped Theranos' culture.

“In 2009, she's running out of cash again.”

The Walgreens Deal and Its Deception

20:20 to 22:00

Investigate the deceptive practices used to secure a deal with Walgreens.

“And while she was keeping converts on side, Sonny would play the bad cop in this relationship.”

The Role of Stealth Mode in Startups

22:00 to 23:30

Understand why Theranos operated in stealth mode and how it affected perceptions.

“This was before they'd seen Theranos' lab or a working demo.”

The Consequences of Ignoring Scientific Rigor

23:30 to 25:50

Learn about the risks of forgoing peer review in health tech startups.

“and it also gives you an excuse to make all your key employees sign non-disclosure agreements.”

Theranos' False Promises and Lavish Lifestyle

25:50 to 28:00

Explore the contrast between Theranos' promises and the reality of its operations.

“He died from liver failure, having attempted to take his own life.”

The Illusion of Success: Image vs. Reality

28:00 to 29:09

Explore how Elizabeth Holmes crafted an image of a successful CEO while ignoring warnings about her company's technology.

“She was charging it all to the company, saying that it was important for Theranos's image.”

Rise to Fame: Valuations and Media Attention

29:10 to 31:25

Learn how Elizabeth Holmes gained media attention and investor confidence despite underlying issues in her company.

“In the article, Elizabeth said, it's kind of like proper text speak this, this is about being able to do good.”

Investigative Journalism: Uncovering the Truth

31:26 to 32:45

Discover the role of investigative journalism in revealing the reality behind Theranos's technology.

“His investigation soon uncovered that the company's technology couldn't reliably perform the full range of tests from just a few drops of blood.”

Regulatory Backlash and Corporate Fallout

32:46 to 34:28

Understand the consequences Theranos faced from regulatory bodies and the subsequent collapse of partnerships.

“citing 14 concerns and called the nanotainer an uncleared medical device.”

The Trials and Sentencing of Elizabeth Holmes

34:29 to 36:48

Follow the legal journey of Elizabeth Holmes as she faces charges and consequences for her actions at Theranos.

“On the 14th of June 2018, Elizabeth Holmes and Sunny Balwani were charged with multiple counts of wire fraud and conspiracy for misleading investors and patients about Theranos' blood testing technology.”

The Financial Downfall: A Cautionary Tale

36:49 to 38:14

Examine the financial repercussions for Elizabeth Holmes and what it reveals about the startup culture.

“Give me some petty cash out of the till to pay for my private jets and my nice tables.”

Assessing Wealth and Controversy: A Scorecard

38:15 to 39:29

Evaluate Elizabeth Holmes's journey through the lenses of wealth, controversy, and philanthropy.

“And also one of the most spectacular and rapid falls from wealth we've seen.”

Legacy of Elizabeth Holmes: From Hero to Cautionary Tale

39:30 to 41:22

Explore the lasting impact of Elizabeth Holmes's story on business ethics and startup culture.

“I mean, the whole story is one of controversy.”

The Cautionary Tale of Elizabeth Holmes

42:00 to 42:50

Explore how Elizabeth Holmes' actions serve as a cautionary tale for startups.

“Apparently, this tale is being taught to business school students as a kind of cautionary tale of startup culture.”

Legacy and Impact on Female Founders

42:50 to 44:00

Discuss the legacy of Holmes and its effect on perceptions of female entrepreneurs.

“Like if Elizabeth Holmes wasn't interested in biotech and she was interested in, say, you know...”

Financial History and Human Impulses

44:00 to 45:18

Analyze the relationship between human behavior and financial scandals across history.

“Obviously, she's not very powerful now, but in terms of legacy, I think she's up there with some of the biggest kind of scandals and scams of the 21st century.”

Did She Know? The Core Question

45:18 to 46:28

Contemplate whether Elizabeth Holmes was aware of her technology's shortcomings.

“You know, these are all things that have been happening for centuries.”

Listener Feedback and Engagement

46:28 to 47:04

Share listener feedback on previous episodes and thoughts on billionaires.

“I still don't know maybe even after this episode.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00This BBC podcast is supported by ads outside the UK. America is changing. And so is the world. But what's happening in America isn't just a cause of global upheaval. It's also a symptom of disruption that's happening everywhere. I'm Asma Khalid in Washington, D.C. I'm Tristan Redman in London. And this is The Global Story. Every weekday, we'll bring you a story from this intersection, where the world and America meet. Listen on BBC.com or wherever you get your podcasts.

0:47It's March 2004. A 19-year-old chemical engineering student walks into her professor's office at Stanford. She's quitting Stanford to build a patch that can diagnose illness and deliver treatment, an idea that sounds more sci-fi than startup. He sighs he doesn't want her to drop out, but he is intrigued. Her approach to complex problems is unlike anything he's ever seen. After listening and seeing her enthusiasm, he tells her to go for it. And he accepts a seat on the company's board. That company is called Theranos, and it's about to take Silicon Valley and the world by storm. But its meteoric rise won't last.

1:24Welcome to Good Bad Billionaire from the BBC World Service. Each episode, we pick a billionaire and find out how they made their money. We take them from zero to their first million, then from a million on to a billion. I'm Simon Jack. I'm the BBC's business editor. And I'm Zing Zing, and I'm a journalist, author and podcaster. And that student was Elizabeth Holmes, once hailed as the next Steve Jobs, complete with black turtlenecks, market-disrupting ideas. By 30, she was crowned the world's youngest self-made female billionaire with a net worth of$4.5 billion. Her company promised to revolutionise healthcare, offering over 200 blood tests from just a single drop of blood.

2:01and she raised over$900 million from investors including Rupert Murdoch and Larry Ellison. But in 2015, a Wall Street Journal expose revealed the truth. The tech didn't work and the promises were fiction. Next, Holmes was convicted of fraud and sentenced to 11 years in prison and her net worth slashed from$4.5 billion to zero. Wow. So how did she go from being teenage prodigy to biotech billionaire and then to inmate? Let's rewind and take Elizabeth Holmes from zero to her very first million.

2:38Elizabeth Ann Holmes was born on February 3rd, 1984 in Washington, D.C. Her father, Christian Holmes IV, held senior roles in various U.S. government agencies and her mother, Noel, worked on Capitol Hill. Both sides of Elizabeth's family were packed with people who'd achieved great things. On her father's side, the Fleischmann yeast fortune and a pioneering doctor who founded the University of Cincinnati Medical School and on her mother's side, a top Pentagon official and further back, even a general who had served under Napoleon. Talk about a lineage. Blimey. Well, the Holmes family had once been very wealthy, but her father said that the fortune had faded thanks to alcoholism, multiple marriages in earlier generations.

3:18And Elizabeth told the New Yorker magazine, I grew up with these stories about greatness and about people deciding not to spend their lives on something purposeful. And what happens to them when they make that choice? John Carreau, whose award-winning book, Bad Blood, Secrets and Lies in a Silicon Valley Startup, has been one of the sources for this episode. He reported that a family party, a young Elizabeth was asked what she wanted to be when she grew up. And her answer was not astronaut or scientist or physicist. It was... Or even millionaire. Or even millionaire. No, she said a billionaire.

3:50She wanted to be a billionaire. And when someone suggested, you know, Elizabeth, maybe you could try being president, she said, no, the president will marry me because I'll have a billion dollars. She was a bit of a child prodigy. She told the New Yorker she read Moby Dick, which is a big book for those who don't know it, from start to finish when she was nine. And she tried to design a time machine when she was seven. She said, the wonderful thing about the way I was raised is that no one ever told me that I couldn't do these things. Yeah, it's interesting that she said she wanted to be a billionaire at that age, because I think if you rewind, this was in the 90s, and I think there were only about 300 billionaires in the world.

4:26It was a rarefied thing. Billionaire status is, well, as we know from this programme, widespread. But no, then it was a very rare beast indeed. Well, as a teenager, Elizabeth's family moved to Houston, Texas, for her father's new job at Teneco, and then at Enron, which she later lost when that company collapsed. Elizabeth and her brother Christian enrolled at St John's School, which was one of the top private schools in Texas. And in her second year, she really threw herself into school. She worked late into the night to become a straight A student. So hard worker. She hasn't really talked about any hobbies or interests as a child, but she was on her school's athletics team.

5:03A teammate was interviewed for ABC News, the Dropout podcast, and explained that Elizabeth often came last when she was in the long distance races. But she said Elizabeth wasn't really bothered by people laughing at her or people crossing the field because she was so far behind. She was going to run that race and finish it, determined to do it no matter what anybody said. So some interesting character traits there. And that determination got her into, well, our old friend and billionaire seeding birthing ground. Cresce. Cresce. Stanford University. Yes. She got onto Stanford's college level Mandarin courses while she was still at high school.

5:35This is going to become increasingly important in the story. So park that in your mind. In 2002, she also secured a place at Stanford as a chemical engineering major. She was also a President Scholar, which is really prestigious. That earned her a$3 ,000 grant to work on a research project. Yeah, so she's an academic bombshell. As a freshman, she persuaded Professor Channing Robinson to let her work in his lab, an opportunity usually reserved for graduate students. That summer, her fluency in Mandarin helped her get an internship at a lab in Singapore, testing specimens for SARS, I remember that, and the samples were collected using syringes and nasal swabs, which got her thinking about less invasive methods of taking samples.

6:17Back in the States, she spent five days and nights with her mum just popping in to give her food, drafting a patent for a skin patch that could diagnose illness and deliver treatment. And her design used something called microfluidics, which is a field focused on moving tiny amounts of liquid through microchannels. Now, at the time, it showed promise in lab settings, but using it in a wearable device for real-time diagnosis and drug delivery, that was well ahead of what the science had actually achieved. And when Elizabeth showed it to one professor at Stanford, they were unconvinced that it could ever work.

6:50But when she showed it to Channing Robertson, he encouraged her to keep developing the idea. In March 2004, Elizabeth decided to quit Stanford in proper billionaire style to pursue her idea full time. She asked Professor Robertson to join her new company as a board member. He agreed. And that is the moment we opened this episode with. Robertson later told Bloomberg's Businessweek magazine, I think there are people who are the Mozarts and the Beethoven's and the Newtons, the Einsteins and the Da Vinci's who come along rarely in a generational sense. It was becoming more and more clear to me that she had it.

7:24Well, to get her start up off the ground, Elizabeth began fundraising close to home. So her parents gave her the money. they'd say for a college fund. Several relatives invested as well. And she created a 26-page pitch deck for the TheraPatch. And this patch, she explained, would use microneedles to painlessly draw blood, analyse it using a microchip, and then deliver the precise amount of medicine needed. Now, I'm no medical technologist, but already this is starting to sound a little bit far-fetched. Yeah, I don't know, though. I mean, if you think that you can apply patches to push stuff in, like nicotine patches, If you can use a patch to push stuff through the skin that way, maybe you can use a patch to pull stuff out the other way.

8:05But all in one? I don't know. How big is this patch going to be? Let's see how this goes, shall we? Still on the hunt for funding, Elizabeth called her childhood friend's father, Tim Draper, one of Silicon Valley's top venture capitalists, people who put money in early stages. He'd been an early investor, for example, in Hotmail. Draper was impressed. He became one of her first investors, put in a million dollars. Elizabeth then approached family, friends, and Professor Robertson put her in touch with some funders too. All told, by early 2005, at the age of 20, without a degree, Elizabeth had raised$6 million, and Theranos itself was now valued at$30 million.

8:41Now, if you're listening to this and you're scratching your head and thinking, raising millions this quickly came surprisingly easy for a 20-year-old dropout, maybe it's worth reminding you of the kind of freebrow atmosphere that Elizabeth was working in at that moment in time. Definitely. So we've had the dot-com boom and bust where fortunes were made and fortunes were lost. 2004 was something of a comeback year. People from the PayPal mafia, as it's known, Peter Thiel, for example, made his angel investment of$500 ,000 in Facebook. If you want to know more about Thiel, fascinating story. We've covered him in another episode.

9:15We also had the Google IPO. That was actually a massive success. Just gave that feeling that Silicon Valley was getting back in gear, confidence was returning. And everyone knew that from the wreckage of the dot-com bust, massive companies were going to emerge and people didn't want to miss out on the ones when they did. She's, you know, a prodigy. She's dropped out of Stanford. She's ticking a lot of boxes here. And massively well-connected. Yes, I think this is it. You know, it's one thing to have a good idea, but if you don't have the connections to back you up with cash, then you're just some schmuck in a bar talking about the next big thing.

9:49And Elizabeth was not that person. No, for sure. So although Elizabeth's$6 million was raised to fund her startup by the beginning of 2005, it's safe for us to say that she is now a millionaire.

10:12So let us take Elizabeth Holmes from a million to a billion. Elizabeth hired a small team. She set up shop in a rundown part of Silicon Valley. It was actually so run down that her car window was once shattered by a stray bullet on her way into the office. So, you know, this wasn't the kind of glitzy, glamorous Facebook campuses that we know of in Silicon Valley. Elizabeth was working on the patch and after further research, she saw that it just didn't work. So she just quickly pivoted. The blood will be collected in a kind of cartridge about the size of a credit card. You'd insert this card into a tabletop machine.

10:47That would then use the microfluidics we talked about to process that sample you would then send the results wirelessly to doctors who could immediately have a look at it and help patients now at home blood monitors are already around anyone who's diabetic will know this think of those handheld glucose meters but elizabeth imagined device that could run dozens of different lab tests for lots of different conditions all from a single drop of blood so it's not quite the patch but i still think a machine that you just need a single drop of blood for is quite attractive to people oh for Sure. I think it's quite interesting that her original patch idea didn't work.

11:20That didn't deter her at all. She immediately pivoted into something else. Okay, we've got money, we've got backing, let's pivot a bit. Pivot is one of their favourite words in technology. By the end of 2005, the company had two dozen employees. They had a prototype, Theranos 1.0, but testing and refining the prototype burnt through that initial$6 million investment. So Elizabeth was working nonstop. She was trying to raise more funds and her dad managed to get her a call with Don Lucas, who's a pioneer venture capitalist and a founding investor in Larry Ellison's Oracle. It's hard to overestimate how big a thing Oracle was, particularly in these years.

12:00You know, when I used to go to California to visit friends who worked in this industry, nobody I knew hadn't spent some time at Oracle. Oracle was a kind of feeding ground for all sorts of tech people. Larry Ellison, you know, briefly became the richest man in the world. Actually, you know, overtook Musk just for a second. So these are very, very important people. Elizabeth took this call to Don Lucas while she was in China. And Lucas was impressed when he heard her speaking Mandarin and arranged to meet her. And these people get phone calls all the time for people looking for money. After the meeting, Lucas agreed to invest in Theranos and introduced Elizabeth to Larry Ellison.

12:38He also invested in what they call a Series B round. This is the second round of funding that raised$9 million in early 2006. Series C funding a few months later raised over three times that,$28 million. And there's a snowball effect when you get names like Lucas and Ellison attached to this company. That same year, 22-year-old Elizabeth was profiled in Inc. magazine alongside other young entrepreneurs, like a young fellow called Mark Zuckerberg, who is exactly the same age. You know, as someone who does speak Mandarin, Mandarin has this very odd effect on people where if they hear you speaking it, they don't have to understand what you're saying.

13:12They don't even have to know if you're speaking it well. It has this effect of people suddenly going, oh, wow, this person must be smart, especially if they're not actually of Chinese heritage. I think this is what was happening here. I think it's seen as somebody who, far thinking enough into the way the world economy is moving and shaping and heading, that they've taken the time to learn what is quite a difficult language. My brother tried to teach me some words. He speaks a bit. He lives in Beijing now. And it's, you know, it's tough. Yeah, you know, you could be ordering a bowl of noodles.

13:44It doesn't matter. All you need to do is give a convincing impression that you are speaking it. Everyone just looks across the room and goes, wow. Well, I actually looked at that pitch document that young Elizabeth was giving out to investors. And it's interesting because it's very snazzy, it's very professional, but it also doesn't offer a lot of information about how the technology works. Yeah, there's a lot of jargon in there, which I honestly don't understand. But most of it is to do with kind of, you know, sales targets and market penetration and size of market and opportunity, whatever. There's very little of granular medical information in it.

14:18And I think that was it's all about getting the money rather than proving that the actual product works. Yeah. And I feel like that should have been a red flag to investors. But maybe at that point, you don't really care. You just want to know you're not missing out. Well, look at who the people on her board are. They're not medical types. She's not surrounded by clinical expertise here at this stage. This is all still fundraisers of people who think this might be a good idea. And she's got money, but she still needs the deals to bring in the revenue. Because there's this wonderful bit in Silicon Valley when we are pre-revenue and pre-profit.

14:50And so you need deals to start bringing some of that in. So in 2006, the team flew to Switzerland to pitch a drug company called Novartis on using its blood testing tech in clinical drug trials. But the night before the demo, the Theranos prototype kept giving error messages. And unable to fix it, Elizabeth's team faked the result during the presentation. They used an earlier reading, which was correct, to make it look like the machine was working. And this is really, I think, the sliding doors moment when things start spiralling. You're not the only person who said uh-oh because Theranos' chief financial officer at the time was not comfortable about this fake result.

15:28When he raised his concerns with Elizabeth about this Switzerland meeting and other possible fake demonstrations for investors, she replied, I don't think you are a team player. I think you should leave right now. So this seems to be, as you say, where the reality of the company's product and the fundraising narrative begin to slightly diverge to protect this narrative. Anyone raising doubts was not welcome. And also, it's important to say that this actually isn't how a lot of science works, right? So a lot of science is looking at what came before, innovating on it or criticising it. Peer review.

16:01Peer review studies. You know, this isn't how one should go about creating scientific advances. Nevertheless, she decides to put even more pressure on her teams. Yeah, so she created a competition. So one group worked to improve the original microfluidics-based prototype. Another one developed a new design. The new design won. The head of the original team was fired. So that, I think, tells you a lot about her personality and her way of dealing with conflict. Yeah, this thing was called the Edison, and it used a mechanical arm to move blood into vials. Less revolutionary than promised. It abandoned the innovative microfluidics vision, which was so central to the original plan.

16:39It adapted technology that was already around into a slightly smaller form. And even though the product no longer used true microfluidics, Elizabeth continued to claim it was central to Theranos' technology when pitching to investors. So basically, she's still saying, oh, this is so important. This is at the heart of my innovation. It's actually not really at the heart of the innovation anymore, but let's keep telling them that. So by 2007, Elizabeth was telling her board she had various pharmaceutical deals lined up. But when board member A.V. Tivanian, a former Apple exec, close friend to Steve Jobs, asked about the details, Elizabeth just dodged his questions.

17:14And when he took his concerns to Don Lucas, who is now chairman of the board, Tavani was pressurised to resign. So again, a really kind of ruthless approach to dissent. By 2008, there were other board members raising flags as well. They were concerned about the disparity between the glowing revenue forecasts and delays in product development. Elizabeth faced a threat that quite a few of our billionaires actually have faced from time to time, including Elon Musk, an ousting by the board. The board questioned whether Elizabeth was too young, too inexperienced. But after a two hour meeting, she brought them back on board, talked them down and managed to stay in charge.

17:51I'm not sure how she managed to pull this off, to be honest. I have to say, looking at interviews of her, there is a kind of odd charisma. And I think that if she kind of turned that attention on you, you kind of feel, well, she's clearly a bit of an oddball, but she believes in it. And also there is this kind of culture in tech, which is that this person might be crazy or they might be a genius. And, you know, maybe I'll lose a few million dollars. Maybe I'll make billions. If you are committed and strident and enough of a believer, sort of messianic, if you like, then there is there's some room for that, you know, amongst these board.

18:29And that's clearly what she had. There's probably a really interesting academic paper to be done into the effect of groupthink in funding rounds. But, you know, they're spending money there in Austin. In 2009, she's running out of cash again. Yeah. And this time, Elizabeth asked her boyfriend, Sonny Balwani, for help. Now, Elizabeth had met Balwani, who was on the same Mandarin course she'd attended in China the summer before she went to Stanford. She was 19. He was 37. He'd sold a software company for$40 million just before the dot-com crash. and like many of the funders, he had no biotech experience.

19:03Their relationship was also secret, but he loaned Theranos$10 million and then became its president. And by this point, Elizabeth was fully channeling her idol Steve Jobs. She was wearing the famous black turtleneck. She adopted a deeper voice, shades of Margaret Thatcher there, lived on green juices, Jobs preferred orange ones, carrot ones. And she'd also been hiring ex-Apple staff, including a designer tasked with making the Edison look as sleek and consumer-friendly and as cool as an iPhone. When Steve Jobs died in 2011, she got a Theranos employee to order a custom-made Apple flag and had it flown at half-mast at Theranos HQ out of respect and in his honour.

19:42Now, Elizabeth styled herself as a revolutionary. She was channelling jobs with these big, world-changing promises. When she took the staff on a Christmas outing, she told them that the prototype they were working on was the most important thing humanity ever built. everyone needs to work as hard as humanly possible to deliver it. And despite their growing doubts, the vision kept staff on board. And as an eventual whistleblower called Tyler Schultz put it in Alex Gibney's documentary, The Inventor, I would leave the lab thinking, oh man, sinking ship. And I would go have one conversation with Elizabeth and I felt like I was changing the world again.

20:18Amazing. Just that kind of talismanic quality to be able to convince people. And while she was keeping converts on side, Sonny would play the bad cop in this relationship. He was known for fostering a culture of fear at Theranos. The firings were so off frequent. Employees darkly joke that Sonny disappeared them like some sort of mafia boss. He also monitored staff, judged commitment by how long people stayed at their desks. All the things we're told we're not supposed to do. I mean, all in all, Theranos sounds like a delightful place to work. So in 2010, Elizabeth pitched Theranos's blood testing tech to a US pharmacy retail chain called Walgreens.

20:56Walgreens is massive. You'll have Walgreens in every single city. Like the boots of America. Exactly. So to secure the deal, she gave the executives there this glowing report of Theranos's technology bearing the Pfizer logo, the big pharma company. That basically falsely implied that Pfizer had authored the report. And in reality, Theranos had only conducted an internal study using their machines in 2007 involving cancer patients, which was then submitted to Pfizer for review. But the Pfizer scientists had actually found that data unconvincing and concluded the technology lacked sufficient scientific support.

21:30So as a result, Pfizer ended its relationship with Theranos in 2008. Did she mention any of this while speaking to Walgreens? Absolutely not. Two uncomfortable dynamics at play here. One is that Pfizer scientists are saying we don't think this data is very convincing and removing their name from their research. Just as she's reaching out to the consumer medical marketplace with Walgreens. And in 2010, Walgreens agreed to a preliminary deal to pre-purchase up to$50 million worth of cartridges and loan the company a further$25 million. This was before they'd seen Theranos' lab or a working demo.

22:07And in fact, the Walgreen executives tried to visit the lab, but were given excuses and ushered into a boardroom. And when they asked even to use the toilet, they were escorted by Theranos staff so they couldn't even have a peek into the labs. Now, this secrecy might seem extreme and also an extreme red flag. But Theranos often emphasised the importance of keeping in stealth mode to protect the proprietary information. And stealth mode is an actual term used in tech, right? It's when a startup deliberately stays out of the public eye. It keeps things, you know, secret so it can focus on research and development without outsiders interfering or spying on them.

22:44And a lot of Silicon Valley startups actually begin in so-called stealth mode. So there's a 2019 study that found that over half of 18 tech unicorns, which are the ones valued over one billion, had no highly cited research papers. But the author of the study and medicine professor John Iomedes points out that health startups need to be peer reviewed. You know, in his words, this is not a laptop or a mobile phone. This is life and death. Yeah. Now, there's perfectly good reasons you might want to be in stealth mode. If you've invented something which you don't want anyone else to look at and try and beat you to the punch, then you'll keep it under wraps.

23:18But crucially, there's another feature of stealth mode. It creates a sense of secrecy and buzz. I can get into the next big thing and no one knows about it. You know, when you've got a kind of, if you like, cultish culture, for want of a better word, at a company, stealth mode fits into that kind of world. and it also gives you an excuse to make all your key employees sign non-disclosure agreements. And you can imagine it, right? I can imagine a Walgreens executive kind of being ushered past the closed doors of the lab, wanting to take a peek and someone saying, oh no, we can't do that. We've got so many competitors.

Read the full transcript

23:49You know, the tech is super top secret. The R &D is completely next level. We can't just let anyone see it. And rather than thinking to yourself, okay, well, something seems a bit off. You just think, oh wow, it must be really good then. Walgreens, who did have doubts about Theranos, especially after Elizabeth refused to allow a comparison study of its blood testing technology, the fears of losing out to the rival company CVS, another big brand of pharmacies in the US, pushed the deal forward. Theranos was also in talks with Safeway. Safeway department store were hoping to revitalise its brand and loan the company$30 million and committed to renovating stores for actually in-store blood testing clinics.

24:25Yeah, so Walgreens executives were reassured when Theranos said Safeway had agreed to host blood drawing sites. So they thought, hey, if Safeway trusts Theranos, we can trust Theranos. So you can absolutely see the kind of groupthink emerging here. But what neither Safeway nor Walgreens knew was that the technology just wasn't ready. Theranos' machines often failed or they simply weren't finished. So they secretly were using third party lab machines to produce all their results. Elizabeth and Balwani claimed they performed 90 % of the most commonly used blood tests, when in reality, their machines could only perform a dozen tests.

25:00Now, who knows, maybe if they'd spent longer on this, and maybe if they peer-reviewed it and da da da, it might have worked. It clearly wasn't at the stage of development that was necessary for it to be rolling out to mainstream America. It's interesting, right? Because I think, you know, anybody who's worked in tech and has rolled out a product that, you know, maybe wasn't quite ready to launch an app that maybe is a little bit glitchy, doesn't have a great user experience, they can think to themselves, well, we can just fix those bugs in the next update. But this isn't an app. And it was while working towards this Walgreens launch that Theranos' chief scientist, Ian Gibbons, repeatedly raised concerns about the accuracy of the technology.

25:38His warnings were ignored when he was called to testify against Theranos in a patent suit they were facing. He did want to discuss under oath that he knew the technology wasn't working. And two days before he was due to testify in May 2013. He died from liver failure, having attempted to take his own life. Gosh. Yeah. And in 2022, his widow told CBS News that she believes the pressure at Theranos contributed to his death and said Elizabeth has showed no remorse. Elizabeth has not publicly commented on Gibbon's death. But despite all of this happening behind the scenes, in September 2013, the first Theranos Wellness Centre open inside a Walgreens in Palo Alto.

26:19That's very near Stanford, very near Silicon Valley. Theranos claimed at the time that they could take a small amount of blood from a fingerprint, which could then be used for over 200 tests from cholesterol to cancer. And people in the US at the time could pay$50 for a test for cholesterol. Theranos were charging$2.99. Yeah, that's a sort of revolutionary price point, isn't it, for healthcare? By 2013, Theranos had assembled one of the most impressive boards in Silicon Valley. Former US Secretaries of State George Shultz and Henry Kissinger, former Defence Secretary Jim Mattis and top lawyer David Boyce.

26:53That is quite the list. It's interesting her George Shultz encounter because she'd asked for a 10 minute meeting turned into two hours. Yeah, exactly. He was so impressed he joined the board and he was the one who actually encouraged the other people to follow. So, you know, government heavyweights, but not biotech experts. But they're serious people with enormous clout. So if you're an investor and you say, who's on your board? Henry Kissinger. What? You know, with that kind of prestige, that kind of name recognition, investors were only too happy to shell out more money. For example, Theranos was saying it would earn$165 million in profit on$261 million in revenue.

27:29That's a high profit margin. Those numbers were fiction. Theranos actually made just over$100 ,000 in revenue in 2014, rather than$261 million, but didn't stop Theranos raising the money. They'd raising nearly 200 million from investors in total by early 2014. And in that same year, Elizabeth Holmes fully embraced the billionaire lifestyle. She flew to meetings on private jets. She was regularly accompanied by bodyguards who nicknamed her Eagle One and Sonny Barwani as Eagle Two. She was eating at luxury restaurants. She was buying designer clothes and jewellery. She was charging it all to the company, saying that it was important for Theranos's image.

28:06Theranos' Palo Alto HQ cost a million dollars a month in rent. And Elizabeth reportedly spent$100 ,000 on a single conference table, all part of this carefully curated image of the visionary CEO. Given the fact that she knows, or maybe she's blocked out the fact that lots of people, her chief scientist has been warning, you know, her CFO left, you know, red flags everywhere. And at the same time, you're behaving on private jets as Eagle One and all this kind of stuff. it slips from kind of like confidence into almost delusion. Do you know what I mean? There's something a little bit not right here.

28:42I think this story is an interesting one because you have to wonder, did she realise that the tech was just not working and maybe would never work and she was just deluding herself into believing that at some point someone's going to make a breakthrough, so I need to do what I'm good at doing, which is getting money out of people, or did she know all along the tech would never work and therefore she was just a grifter who was scamming people. Yeah. Meanwhile, in June 2014, Fortune magazine had Elizabeth on the cover and stated that Theranos now had a valuation of$9 billion. In the article, Elizabeth said, it's kind of like proper text speak this, this is about being able to do good.

29:20Consumerising this healthcare experience is a huge element of our mission. But at the same time, Theranos' lab director, Adam Rosenhoff, was telling Elizabeth that some of the tests had unreliable results. He later said she seemed pretty calm about the whole thing. She didn't seem to share my level of alarm. He then quit a few months later. By October, Forbes calculated Elizabeth's wealth to be four and a half billion dollars based on her 50 percent stake in Theranos. She was ranked 110 on their rich list and was, at 30 years old, the youngest self-made female billionaire in America. In a speech she made after becoming a billionaire, she said, I would say that I am living proof that it's true.

29:59If you can imagine it, you can achieve it.

30:15America is changing. And so is the world. But what's happening in America isn't just a cause of global upheaval. It's also a symptom of disruption that's happening everywhere. I'm Asma Khalid in Washington, D.C. I'm Tristan Redman in London and this is The Global Story. Every weekday we'll bring you a story from this intersection where the world and America meet. Listen on BBC.com or wherever you get your podcasts.

30:52In 2014 she's a billionaire. Let us take her beyond that and bring it up to date. by 2015 Holmes had raised over 400 million dollars from investors her backers now included the Walton family who own that small little family store called Walmart and Rupert Murdoch you may have heard of big names deep pockets they'd all been told about the company by their lawyer who also happened to be Henry Kissinger's lawyer it is interesting lawyers can sometimes be the grapevine in these circles interesting so in early 2015 the Wall Street Journal reporter John and Cariou got a tip. Theranos wasn't what it seemed.

31:28His investigation soon uncovered that the company's technology couldn't reliably perform the full range of tests from just a few drops of blood. And as Cariou dug deeper, Theranos attempted to silence his sources through legal threats and NDAs. Elizabeth even tried to persuade Rupert Murdoch, who was a major investor, to kill the story. In a September 2015 meeting, she urged him to intervene, but he refused. And in October 2015, The Wall Street Journal splashed on it. They published an expose revealing that Theranos was using third-party machines, raising doubts about the accuracy of blood-testing technology.

32:02Theranos denied the claims, calling the report factually and scientifically erroneous, blaming former disgruntled employees. That same day, Holmes went on CNBC's Mad Money. And CNBC is the kind of thing that gets shown on trading floors and whatever all around the world. It's a kind of financial channel defending Theranos with very calm conviction. on live tv she said first they think you're crazy then they fight you then you change the world but despite all this bravado things were not going according to plan a day after the article was published theranos halted use of their nanotainer the small valve that they were using to collect the finger prick blood in for all but one test and that was under pressure from the fda food and drug administration yes so a few weeks later the fda then released two reports citing 14 concerns and called the nanotainer an uncleared medical device.

32:51And by January 2016, a US government health agency found such serious issues in the company's lab that it declared Theranos posed an immediate jeopardy to patient health and safety. That sounds like a death knell to a medical company. Yeah, that is a bombshell and a half. So Walgreens had to act. They suspended Theranos's service at its Palo Alto location. They stopped sending lab tests to the company's California lab. They sent it to third party labs instead. A few months later, they ended their partnership, closed the 40 Theranos wellness centres and Safeway, if you remember that deal, the supermarket there, they ended up paying$350 million to Theranos.

33:28But after years of delays, they never even had a rollout of the blood testing services. They didn't even start there. The clinics they built at over 800 stores were instead used for flu shots and travel vaccines. In June 2016, Forbes changed its estimate of Elizabeth Holmes' net worth from four and a half billion to zero. Ouch. And Theranos' market value went from nine billion to eight hundred million. And as Theranos collapsed dramatically, Holmes flew across the country to buy a Siberian Husky named Balto, hoping that it would help to symbolically reboot the company's future. Not sure how a Siberian Husky would do that.

34:04That's the craziest idea I've ever had. I mean, the dog became a fixture at Theranos HQ. Despite not being toilet trained, Balto also had a habit of relieving himself during company meetings. I think that's much more of a symbolic reflection of the company's future. It's a bit of dog mess on the floor. Yeah. Imagine being an employee being told that Theranos is on its way back up. Oh, yes. And Balto's in the corner there relieving himself. On the 14th of June 2018, Elizabeth Holmes and Sunny Balwani were charged with multiple counts of wire fraud and conspiracy for misleading investors and patients about Theranos' blood testing technology.

34:41A day later, Elizabeth stepped down as CEO and did not speak publicly. Holmes was tried first and in January 2022 was found guilty on four counts of defrauding investors. She was sentenced to 11 years and three months in prison and ordered to pay part of a$452 million restitution or compensation. Balwani was tried separately and received an even longer sentence of nearly 13 years. Holmes began her prison sentence in May 2023. She was interviewed by People magazine in February 2025, which said that she works out daily, she eats vegan meals and teaches French to other inmates. She also maintains her innocence in that interview.

35:21And in 2025, despite appeals, both Elizabeth and Sonny's convictions were upheld, along with the full restitution order. They were both acquitted of charges relating to defrauding patients. Between 2013 and 2016, Theranos ran over 1.5 million tests for 176 ,000 patients. More than 10 % of those results were voided or corrected due to errors. Some patients even received false positives for serious conditions like cancer and autoimmune diseases, leading to unnecessary treatments and, of course, emotional distress. In 2023, Walgreens agreed to a$44 million settlement with the patients who received Theranos blood tests on their premises.

36:01Each patient got a$10 base payment. That's double the cost of the test and up to$1 ,000 if they'd undergone finger prick testing. Now, what happened to those investors? Rupert Murdoch sold his stock back to Theranos for a dollar to claim a tax write-off and other earnings. He lost£121 million but got£4 million back under legal settlement. But not all the investors who lost their money were wealthy enough to pay for their lawsuits. ABC's The Dropout podcast featured a woman who lost her life savings, $150 ,000, investing in Theranos through her financial advisor and a man who lost$1.2 million, advised again by a financial advisor, testified at Elizabeth's trial.

36:40During the trial itself, it was revealed that Elizabeth Holmes received an annual salary of around$200 ,000 while at Theranos. But she also owes over£25 million to the company taken out in three promissory notes. Basically, an IOU from the company. Give me some petty cash out of the till to pay for my private jets and my nice tables. And I promise I'll pay you back out of my vast fortune when Theranos is a well-beaten company. Well, guess what? None of those promissory notes have been repaid. Holmes is also now in a relationship with a hotel heir called Billy Evans. And they have two children, a son born in 2021 and a daughter born just months before Holmes entered prison.

37:20Anyway, it's time for us to judge Elizabeth Holmes or for you to judge Elizabeth Holmes. We score our billionaires in a few different categories, wealth, controversy, philanthropy, the legacy they've left behind from one to 10. And we always start with wealth. I mean, came from a once rich family, very well connected, had tales of greatness in the family's past. So quite a fertile ground for people to believe that you could go and achieve something. This wasn't someone telling you you can't do stuff. And at the height of that wealth, she was worth, what, four and a half billion. Spending wise, you know, she was flying private jets.

37:57She was having a luxurious lifestyle all on the company dime. Apparently she paid nine million dollars for a five bed mansion in Silicon Valley. So, you know, she was living the life of a billionaire. But it has to be said that, you know, she's now been reduced to earning 31 cents an hour as a re-entry clerk in prison. Gosh, she's making me feel well off. And also one of the most spectacular and rapid falls from wealth we've seen. Four and a half billion in 2015, zero in 2016. I think only Sam Bankman-Fried can rival that in terms of a fall from financial grace. And of course, he's also still in prison too.

38:30He's still in prison, yes. on wealth. You know, she was at one point the youngest self-made female billionaire in the US, in the world. In the world, yeah. So at her height, you know, she was flying pretty high and then what a spectacular fall. Have you heard of this phrase, girl bossing too close to the sun? No. It's very good. It basically applies to female girl bosses, you know, that kind of Elizabeth Holmes type female figures who kind of put themselves out there as these innovative, charismatic messiahs who will change the world who also happen to be women. So it's a feminist win. And they simply go boss too close to the sun.

39:07Really? Yeah, well, this is definitely an example of that. Got it. I just think the wealth is kind of interesting. So I'm going to give her a, even though it's not that much money in the sort of big leagues, it's quite an interesting trajectory. So I'm going to give her a six. Yeah, I think she's a six out of 10 for me from wealth, even though she is technically, I suppose, worth nothing right now. Okay, let us move on to controversy. Well, where do we start? I mean, the whole story is one of controversy. Yeah, with a capital C. Defrauding investors, you know, lying to their faces, even fabricating reports that the technology was working.

39:45Yeah, and convince some of the, you know, wisest people in America, you know, people like Henry Kissinger, George Shultz. You've got Larry Ellison involved, Don Lucas. These people are heavyweights. Yeah. And if you look at pictures of Elizabeth from the time that she was riding high, it is quite a sight. It's this very young looking blonde woman. She's got these enormous kind of quite glassy eyes, black turtleneck. And she's surrounded by these much older men who have, you know, been in politics, been in, you know, the finance world, been in tech for decades longer than she has. And she's sort of there staring at all of them like, give me the money.

40:22I think we should also have a very important shout out to Ian Gibbons, who was the chief scientist at Theranos, who tried to take his own life and died of liver failure. He had had grave concern and his wife was clear that something about the company Theranos contributed to his death. So I think you've got to give this controversy. I'm giving it a 10. I think it's a 10 out of 10 for me. Yeah. OK. I don't think you can come up with a greater cautionary tale in tech. No. Philanthropy. As usual, there doesn't seem to be a lot of public information about her philanthropy. And it seems on this occasion, it's not just because there's lack of information because she didn't want it to be known what great things she was doing.

41:02It seems more likely that there wasn't any. Now, interestingly, there is a company called Wealth X, which helps charities check if their donations are from legit companies. Before the Theranos scandal broke in the news, there were apparently some clients at Wealth X who wanted to add Elizabeth Holmes to their charity boards. But reportedly, this wealth ex-company were advising people from adding her because they were actually quite wary of Theranos' claims. Wow. So what does that mean? A zero for a philanthropy? It's a zero for me, I think. In fact, they're probably anti-philanthropic. This is a judging round of extremes.

41:37We're from 10 to zero. Power and legacy. It's a hell of a tale, this one, isn't it? So I think that the legacy is all in the kind of folk tale that she's drawn during this. apparently, and maybe if you are at business school listening to us right now, I know there are some people who do. Drop out now, you'll become a billionaire. Just kidding. Learn Mandarin. Maybe that's a better learning from this episode. Apparently, this tale is being taught to business school students as a kind of cautionary tale of startup culture. It is absolute worst. Yeah, but in some ways, you could say it's a cautionary tale because she was dabbling in medical technology and therefore the stakes are incredibly high and something was bound to go wrong.

42:19If this had been a, you know, phone that wasn't very good or a service that didn't quite work. Or a VR headset. Yeah, right, exactly. Then she would probably be, you know, lionised as a hero and she would probably be starting another company as we speak right now. And, you know, the fake it till you make it story is not just a cautionary tale. It's kind of a guidebook in some ways, right? In some cases, it's, you know, that's the way you do business. And actually failing a couple of times are seen as a badge of honour in tech world. I wonder if this is just an example of a fatal mismatch. Like if Elizabeth Holmes wasn't interested in biotech and she was interested in, say, you know...

43:00Dating apps or something. Dating apps or HL organisational software. Yeah, exactly. You know, would this fake it as you make it attitude, would it have such serious consequences? I don't think so. No, exactly. I mean, it was basically the fatal flaw in that was that she went after an industry where you basically need to be quite transparent with your technology, with your scientific advances, because that helps you be better. Yeah, yeah. When the FDA come in to shut you down, essentially, then you know you're in a different kind of business. What about, you know, I'm just trying to think if she's helpful or not helpful to female founders.

43:37You know, people say, oh boy, here's another Elizabeth Holmes on her hands. There have actually been some female founders who say that it's actually been bad for them because now people scrutinise female founders more closely because they're worried that they're just another Elizabeth Holmes. That's spectacularly unfair, isn't it? It really is. I'm going to give her a seven for legacy. They'll be talking about this tale for a long time. I think so. I think actually I would give her... Obviously, she's not very powerful now, but in terms of legacy, I think she's up there with some of the biggest kind of scandals and scams of the 21st century.

44:12So I'm going to give her an eight. Okay, fair enough. Final reflection. It's one of those stories that doesn't come along very often, isn't it? The thing about this podcast series is that we've seen quite a lot of fortunes made quickly and then lost quickly. And the kind of money that people have made is something that we've never seen in any period in history ever before. Sam Bankman-Fried, for example, went from zero to 18 billion and then down to zero again. She went from next to nothing to four and a half billion, then down to zero again. I think this story will stay with me and with the canon of financial history for a long time.

44:48And yet at the same time, even though we're at a period where people are making and losing more money than ever before in human history, it seems like human impulses and human thinking is still very much the same as it's always been. You know, the effect of groupthink, of herd thinking, the fear of missing out, the ability of people to create themselves as kind of messianic figures, to create cults of personality that encourage people to see past big red flags. You know, these are all things that have been happening for centuries. It's just that the money involved is so much greater now. And it's interesting.

45:25I was more moved by the woman who'd lost$150 ,000 in her life savings and the guy lost$1.2 million, most of his net worth, than I am about the Rupert Marduk, who's$121 million of theirs. I mean, they are used to the fact that they've got many multi-billions. They put$20 million into something, put$100 million in there. One of these things will hit the cover off the ball and be worth a trillion and the other one will crash and burn. And they don't care. Do you know what I mean? That's the risk they take. They're grown up. They've got their eyes wide open. And it's different when it's medical technology, I think, like we were saying, whether it's a car or a smartphone.

46:00But it's those people, I think, who got swindled into believing in this, who lost big parts of their personal net worth. For everyone else, it's part of the game. Yeah, I mean, it is a fascinating story. And I think I keep coming back to that question of, did Elizabeth Holmes know that the tech didn't work? and she either deluded herself into believing it would be fine or did she just simply not care and she was just scamming her way to the top? I don't know. I still don't know maybe even after this episode. What do you think? I'm not so sure, but I think it gets right to the heart of whether she's good, bad or just another billionaire.

46:37What do you think? Please do email goodbadbillionaire at bbc.com or drop us a text or WhatsApp to 001 917 686 1176 tell us what you think. And also don't forget to include your name we may read out your message on a future episode. And a final thanks to John Kerry Roo whose excellent book Bad Blood was one of many sources for this but was an absolute belter of a book. Well we've got some listener feedback Ephraim who is 13 from Ghana got in touch to give feedback on our David Geffen and Sarah Blakely episodes. They said on David Geffen I think David Geffen is just another billionaire he helped pull up other people and also ditched others so he's just in between.

47:19And Ephraim says of Sarah Blakely, I see fashion as waste. But for someone like Sarah Blakely, who's changed how women are viewed in fashion, she's surely a good billionaire. And Scott got in touch from Ontario, Canada. Scott's email and the subject line, almonds, full stop. OK. Scott says, love the show for the insight and fun banter, including January 23rd's show, You Peel Your Almonds. If you remember this, a listener sent in feedback about our Elon Musk episode saying she was listening to it while peeling her almonds. Yes, which I was surprised that that was a thing. Well, Scott, on his part, says he laughed out loud and goes on to say, yes, peeling the almonds makes them creamier in recipes like almond milk and the skins can be ground and used as roughage in face scrubs.

48:02Now have to get back to rolling my pennies. Billionaire not. Thanks very much for getting in touch, Scott. And letting us know how to make good almond milk. So who've we got next? Well, we've got a billionaire who is visionary to some, ruthless to others in the words of one listener who recommended we cover him. He is database mogul. The owner of his own Hawaiian island. And likes to fly fighter jets. Yes, well, he certainly fits the billionaire playboy mold. It's none other than Larry Ellison, the founder of Oracle.

48:38Good Bad Billionaire is a BBC World Service podcast produced by Tamsin Curry. The researcher is Maria Noyan. The editor is Paul Smith and it's a BBC Studios production. For the BBC World Service, the senior commissioning producer is Sarah Green and the commissioning editor is John Lonell.

49:12America is changing. And so is the world. But what's happening in America isn't just a cause of global upheaval. It's also a symptom of disruption that's happening everywhere. I'm Asma Khalid in Washington, D.C. I'm Tristan Redman in London, and this is The Global Story. Every weekday, we'll bring you a story from this intersection, where the world and America meet. Listen on BBC.com or wherever you get your podcasts.

From the publisher

Once hailed as the next Steve Jobs, Elizabeth Holmes became the world’s youngest self-made female billionaire after founding Theranos, a startup that promised to revolutionise healthcare with hundreds of blood tests from a single drop. BBC business editor Simon Jack and journalist Zing Tsjeng trace Elizabeth Holmes’s journey from precocious Stanford student to biotech entrepreneur, before unpacking how secrecy and hype masked a technology that couldn’t deliver. When Theranos collapsed spectacularly, a Silicon Valley dream became one of the biggest corporate scandals of the century. Good Bad Billionaire is the podcast that explores the lives of the super-rich and famous, tracking their wealth, philanthropy, business ethics, and success. There are leaders who made their money in Silicon Valley, on Wall Street and in high street fashion. From iconic celebrities and CEOs to titans of technology, the podcast unravels tales of fortune, power, economics, ambition and moral responsibility. Simon and Zing put their subjects to the test with a playful, totally unscientific scorecard — then hand the verdict over to you: are they good, bad, or simply billionaires? Here's how to contact the team: email goodbadbillionaire@bbc.com or send a text or WhatsApp to +1 (917) 686-1176. Find out more about the show and read our privacy notice at www.bbcworldservice.com/goodbadbillionaire

More from Good Bad Billionaire

All 110 episodes
Elizabeth Holmes: From CEO to criminalGood Bad Billionaire · 48 min
Listen in VO